Mood instability and functional recovery in bipolar disorders

Acta Psychiatrica Scandinavica

Volumn 128, Issue 3, 2013, Pages 194-202

  Strejilevich, S A ^a,b   Martino, D J ^a   Murru, A ^c   Teitelbaum, J ^a   Fassi, G ^a   Marengo, E ^a   Igoa, A ^a   Colom, F ^c  

^a FAVALORO UNIVERSITY   (Argentina)

^b INSTITUTE OF COGNITIVE NEUROLOGY INECO   (Argentina)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; Clinical aspects; Methodology

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CONVALESCENCE; DEPRESSION; DISABILITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HAMILTON SCALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL INSTABILITY; MIXED MANIA AND DEPRESSION; PRIORITY JOURNAL; YOUNG MANIA RATING SCALE;

BIPOLAR DISORDER; CLINICAL ASPECTS; METHODOLOGY;

ADULT; AFFECTIVE SYMPTOMS; BIPOLAR DISORDER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PROGRESSION; EMPLOYEE PERFORMANCE APPRAISAL; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RECOVERY OF FUNCTION; SYMPTOM ASSESSMENT; TIME;

EID: 84881546092     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12065     Document Type: Article

References (47)

1. MacQueen G, Young L, Joffe R. A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand 2001;103:163-170.
2. Keck P, McElroy S, Strakowsky S et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998;155:646-652.
3. Tohen M, Hennen J, Zarate C et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000;157:220-228.
4. Treuer T, Tohen M. Predicting the course and outcome of bipolar disorder: a review. Eur Psychiatry 2010;25:328-33.
5. Wingo A, Harvey P, Baldessarini R. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord 2009;11:113-125.
6. Martino D, Marengo E, Igoa A et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study. J Affect Disord 2009;116:37-42.
7. Solé B, Bonnin C, Torrent C et al. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr Scand 2012;125:309-317.
8. Bonnín C, Sánchez-Moreno J, Martínez-Arán A et al. Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord 2012;136:650-659.
9. Altshuler L, Post R, Black D et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry 2006;67:1551-1560.
10. Tohen M, Waternaux CM, Tsuang M. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990;47:1106-1111.
11. Dion G, Tohen M, Anthony W, Waternaux C. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry 1988;39:652-657.
12. Delbello M, Hanseman D, Adler C, Fleck D, Strakowski S. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry 2007;164:582-590.
13. Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E; Emblem Advisory Board. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 2007;9:45-52.
14. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman G. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993;150:720-727.
15. Vojta C, Kinosian B, Glick H, Altshuler L, Bauer M. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2001;42:190-195.
16. Judd L, Akiskal H, Schettler P et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry 2005;62:1322-1330.
17. Tohen M, Greil W, Calabrese J et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005;162:1281-1290.
18. Chengappa K, Hennen J, Baldessarini R et al. Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord 2005;7:68-76.
19. Rosa A, Reinares M, Franco C et al. Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord 2009;11:401-409.
20. Goldberg J, Ernst C. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry 2002;63:985-91.
21. Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 2008;109:251-263.
22. Suppes T, Vieta E, Liu S, Brecher M, Paulsson B. Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 2009;166:476-488.
23. Bonsall M, Wallace-Hadrill S, Geddes J, Goodwin G, Holmes E. Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder. Proc Biol Sci 2012;279:916-924.
24. Henry C, van Den Bulke D, Bellivier F et al. Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period. Psychiatry Res 2008;159:1-6.
25. Vázquez G, Kahn C, Schiavo C et al. Bipolar disorders and affective temperaments: a national family study testing the 'endophenotype' and 'subaffective' theses using the TEMPS-A Buenos Aires. J Affect Disord 2008;108:25-32.
26. Diler R, Birmaher B, Axelson D et al. Dimensional psychopathology in offspring of parents with bipolar disorder. Bipolar Disord 2001;13:670-678.
27. Bechdolf A, Ratheesh A, Wood S et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des 2012;18:358-375.
28. Tohen M, Frank E, Bowden CL et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009;11:453-473.
29. Glenn T, Whybrow P, Rasgon N et al. Approximate entropy of self-reported mood prior to episodes in bipolar disorder. Bipolar Disord 2006;8:424-429.
30. Sree Hari R, Raghvendra R, Yeragani V. A novel technique to evaluate fluctuations of mood: implications for evaluating course and treatment effects in bipolar/affective disorders. Bipolar Disord 2006;8:453-466.
31. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinical Version (SCID-CV). Washington, DC: American Psychiatric Press, 1996.
32. Ramos-Brieva J, Cordero-Villafafila A. A new validation of the Hamilton Rating Scale for Depression. J Psychiatr Res 1988;22:21-28.
33. Colom F, Vieta E, Martínez-Arán A et al. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med Clin (Barc) 2002;119:366-371.
34. Strejilevich S, Martino D, Marengo E et al. Long-term worsening of bipolar disorder related with frequency of antidepressant exposure. Ann Clin Psychiatry 2011;23:186-192.
35. Rosa A, Sánchez-Moreno J, Martínez-Aran A et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemol Ment Health 2007;3:5.
36. Peralta V, Cuesta M. Escala Clínica de Intensidad, Frecuencia y Duración del Tratamiento Psicofarmacológico (Escala IFD). Pamplona, Spain: Virgen del Camino Hospital, 2002.
37. Carlson G, Kotin J, Davenport Y, Adland M. Follow-up of 53 bipolar manic-depressive patients. Br J Psychiatry 1974;124:134-139.
38. Altshuler L, Gitlin M, Mintz J, Leight K, Frye M. Subsyndromal depression is associated with functional impairment in patient with bipolar disorder. J Clin Psychiatry 2002;63:807-811.
39. Marangell L, Dennehy E, Miyahara S et al. The Functional Impact of Subsyndromal Depressive Symptoms in Bipolar Disorder: Data from STEP-BD. J Affect Disord 2009;114:58-67.
40. Simon G, Bauer M, Ludman E, Operskalski B, Unûtzer J. Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression. J Clin Psychiatry 2007;68:1237-1245.
41. Judd L, Akiskal H, Schettler P et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-537.
42. Judd L, Akiskal H, Schettler P et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003;60:261-269.
43. Bauer M, Kirk G, Gavin C, Williford W. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. J Affect Disord 2001;65:231-241.
44. López-Jaramillo C, Lopera-Vásquez J, Gallo A et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 2010;12:557-567.
45. Martino D, Igoa A, Marengo E, Scápola M, Strejilevich S. Neurocognitive impairments and their relationship with psychosocial functioning in euthymic bipolar II disorder. J Nerv Ment Dis 2011;199:459-464.
46. Murru A, Colom F, Nivoli A, Pacchiarotti I, Valenti M, Vieta E. When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations Eur Psychiatry 2011;26:183-186.
47. Baastrup P, Schou M. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967;16:162-172.